As interest in therapeutic TIDES grows, regulatory agencies are increasingly requiring more rigorous characterization to ensure patient safety, drug efficacy, and quality. To meet these demands, ...
In 2014, Agilent Technologies announced that it would stop selling nuclear magnetic resonance systems. Agilent, which had acquired its NMR rival Varian in 2010, continued to fulfill existing orders, ...
An initial step of most NMR studies is identifying peaks in the obtained spectrum. Producing a peak list is especially crucial if the spectrum is automatically prepared. Peak picking is still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results